Insta
India Likely To Face Vaccine Shortage For Next Few Months: Serum Institute’s CEO Adar Poonawalla
Swarajya Staff
May 03, 2021, 12:45 PM | Updated 12:45 PM IST
Save & read from anywhere!
Bookmark stories for easy access on any device or the Swarajya app.
Chief executive of Pune-based vaccine maker Serum Institute of India (SII), Adar Poonawalla has said that India is likely to face a shortage of COVID-19 vaccines for the next few months, reports Economic Times.
Though SII is presently pursuing an expansion of its capacity to produce Covishield vaccines, Poonawalla said that it had not expanded the capacity earlier due to lack of orders. He said, "There were no orders, we did not think we needed to make more than 1 billion doses a year."
With the expansion of capacity presently underway, SII is expected to increase its production of Covishield vaccines from the present 60-70 million doses a month to 100 million doses from July.
Since the beginning of the nationwide vaccination drive on 16 January, India has so far given at least one dose of either Covishield or Bharat Biotech's Covaxin COVID-19 vaccines to over 157 million people who make up about 12 per cent of the population. Over two per cent of the population has received two doses so far.
Save & read from anywhere!
Bookmark stories for easy access on any device or the Swarajya app.
Introducing ElectionsHQ + 50 Ground Reports Project
The 2024 elections might seem easy to guess, but there are some important questions that shouldn't be missed.
Do freebies still sway voters? Do people prioritise infrastructure when voting? How will Punjab vote?
The answers to these questions provide great insights into where we, as a country, are headed in the years to come.
Swarajya is starting a project with an aim to do 50 solid ground stories and a smart commentary service on WhatsApp, a one-of-a-kind. We'd love your support during this election season.
Click below to contribute.